People | May 01, 2026
Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
Subscribe To Our Newsletter & Stay Updated
